Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Sun Pharma gets go-ahead in South Africa to sell generic semaglutide
Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of…
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn't eliminate that pressure. It did, however, pursue voluntary pricing agreements with many of the industry's largest drugmakers. Since late…
Pharma Cos. Clash In Del. Chancery Over Dental Drug License
Ventis Pharma Inc. has sued Balanced Pharma Inc. in the Delaware Chancery Court, accusing its licensee of failing to make commercially reasonable efforts to develop and market a licensed dental anesthetic... To view the full article, register now.
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion. Index…
OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing
OneSource Specialty Pharma Limited announced a strategic manufacturing partnership with Formycon AG, a Munich-based independent biosimilar developer, today. Under the agreement, OneSource will provide integrated Drug Substance and Drug Product…
Natco Pharma raises Adcock Ingram stake to 49%, pays ₹1,060 crore
Hyderabad-based Natco Pharma Limited on Tuesday completed the acquisition of an additional 13.25 per cent equity stake in South African pharmaceutical company Adcock Ingram Holdings Proprietary Limited, bringing its total shareholding to 49 per…
Why Semaglutide is an inflection point for India's generics sector?
More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India's pharmaceutical industry, which supplies about 20% of the world's generic medicines by…
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
Eli Lilly (LLY 0.09%) and Novo Nordisk (NVO 0.35%) today participate in one of the most exciting growth markets in healthcare: the weight loss drug market, one that's on track to reach nearly $100 billion in a few years. Novo was the first to…
In the Weight-Loss Wars, Novo's Obesity Pill Is Pulling Way Ahead of Lilly's
The launch of weight-loss pills is the hottest battle in pharma. So far, is losing to rival. Since its obesity pill Foundayo hit the market in April, Lilly has captured about 11% of the prescription volume for new pills, according to the latest…
The Race to Commercialize the World's Most Powerful Psychedelic
An obscure and extremely powerful psychedelic called 5-MeO-DMT is drawing intense interest from the pharmaceutical industry, where biotech companies are racing to turn it into a commercially available treatment for severe mental health disorders…
Sensex drops 561 points over West Asia flare-up
Stock market benchmark indices Sensex and Nifty tumbled on Tuesday as a sharp surge in crude oil prices due to the renewed flare-up in West Asia dented investors' sentiment. Fresh foreign fund outflows and the falling rupee also put pressure on the…
HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
HSBC has lost conviction in its buy rating for AstraZeneca and forecasts a 'tough path ahead' for the British-Swedish drugmaker, which last week posted a rare clinical trial failure that sent shares tumbling. The bank's analysts have downgraded the…
Sensex, Nifty Plunge: West Asia Tensions, Surging Crude Oil, Rupee Weakness Impact Indian Stocks
Indian stock markets, including the Sensex and Nifty, witnessed a notable slump as escalating West Asia tensions drove crude oil prices sharply higher, alongside foreign fund outflows and a weakening rupee, impacting investor sentiment. Indian…
India, China trade rises to $91.72bn in first half of 2026
China's exports to India increased by 21.8 per cent in the first half of 2026 to USD 79.41 billion, while Indian exports to China rose 37.2 per cent to USD 12.31 billion, according to data released by Chinese customs on Tuesday. The bilateral trade…
Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?
A high-yielding dividend may sound great for investors, but it can be a double-edged sword: when it's too high, investors start to worry about its safety. That's a big part of the reason why Pfizer (PFE 1.08%), whose 7.1% yield is well above the…
Receive a Daily briefing on Pharma Industry News
Get Started